Skip to content

Early Clinical and Radiological Outcomes of a Novel Robotic TKA System

Early Clinical and Radiological Outcomes of a Novel Robotic TKA System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06638047
Acronym
RA-TKA
Enrollment
144
Registered
2024-10-15
Start date
2022-09-08
Completion date
2024-05-13
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Robotic Surgery, Total Knee Anthroplasty

Keywords

total knee arthroplasty, robot, radiological, clinical outcome, postoperative alignment

Brief summary

This study aimed to evaluate the early clinical and radiological outcomes of robot assisted total knee arthroplasty, and to determine the efficiency and safety of its bone resection and implant positioning of the novel robot system. 144 patients undergoing primary TKA were enrolled in this prospective, multicenter RCT conducted in 3 hospitals. The primary outcome was the rate of patients whose postoperative alignment was less than 3° deviated from the planned evaluated by full-length weight-bearing X-rays of the lower limb at 12 weeks postoperatively. Secondary outcomes will include coronal and sagittal alignment of the components, operation times, blood loss, 12-week range of motion(ROM), 12-week postoperative functional outcomes and satisfaction evaluated by the American Knee Society Score (KSS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and adverse events (AEs).

Interventions

Robotic-assisted TKA means that TKA surgery is operated with the guidance of robotic system.

PROCEDURECI-TKA

TKA operated with conventional instruments

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged 18-85 years (including 18 and 85), regardless of gender; * Patients scheduled for unilateral primary total knee arthroplasty based on the clinical judgment of the study physician; * The subject or their guardian has been informed of the study, agrees to all terms of the trial, signs an informed consent form approved by the ethics committee, and agrees to participate in the trial.

Exclusion criteria

* The side scheduled for surgery has significant hip joint disease, such as substantial bone defects or severe limitations in joint mobility; * Patients with active infections around the knee joint or systemic infections; * Discontinuity or severe functional loss of the knee extensor mechanism, painless knee joint fusion, Charcot joint, poor surgical tolerance, or other conditions that may adversely affect surgical prognosis; * Patients with contraindications for traditional TKA surgery; * Pregnant or breastfeeding women; * Patients known to have excessive alcohol consumption or substance abuse; Body mass index (BMI) \> 35 kg/m²; * Patients who have participated in other clinical trials within one month prior to signing the informed consent form; * Patients with mental or intellectual disabilities that may affect clinical outcome evaluations; * Patients deemed unsuitable for participation in this clinical trial by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
HKA outliers12 weeks post-surgerythe proportion of patients with a deviation of ≤ 3° between the mechanical axis (hip-knee-ankle angle, or HKA angle) measured from a full-length, frontal-view lower limb X-ray

Secondary

MeasureTime frameDescription
Surgical durationDuring operationIn this study, surgical duration is defined as the time from the first incision to the completion of skin closure
FFC angle12 weeks post-surgeryfrontal femoral component (FFC) angle
outliers of FFC angle12 weeks post-surgeryoutliers of frontal femoral component (FFC) angle (\>3 degree)
FTC angle12 weeks post-surgeryfrontal tibia component (FTC) angle
outliers of FTC angle12 weeks post-surgeryoutliers of frontal tibia component (FTC) angle (\>3 degree)
LFC angle12 weeks post-surgerylateral femoral component (LFC) angle
outliers of LTC angle12 weeks post-surgeryoutliers of lateral tibia component (LTC) angle (\>3 degree)
LTC angle12 weeks post-surgerylateral tibia component (LTC) angle
Blood loss3 days after surgeryPostoperative blood loss is calculated using the Gross formula in this study. The Gross equation was used to calculate the total blood loss (mL) as preoperative blood volume×(preoperative HCT level-postoperative HCT level).
ROM12 weeks post-surgeryROM refers to the maximum passive range of knee motion
Knee Society Score (KSS)screening and 12 weeks post-surgery.The KSS, developed by the American Knee Society, evaluates objective knee indicators, symptoms, patient satisfaction, patient expectations, and functional activities. A total score above 85 is considered excellent, 70-84 is good, 60-69 is fair, and below 60 is poor.
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)screening and 12 weeks post-surgery.The WOMAC measures knee function in terms of pain, stiffness, and physical function across 25 items. Pain is assessed with five items, stiffness with two items, and physical function with 18 items. Each item is scored from 0 to 4, with higher scores indicating more severe symptoms.
Incidence of adverse events and serious adverse eventsThrough study completion, an average of 12 weeksThroughout the study, any adverse events that occurred were recorded, and the corresponding incidence was calculated. Similarly, any serious adverse events that occurred during the study were recorded, and the corresponding incidence was calculated.
outliers of LFC angle12 weeks post-surgeryoutliers of lateral femoral component (LFC) angle (\>3 degree)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026